Experts name 2 excellent blue chip ASX 200 shares to buy

These blue chip shares could be buys…

| More on:
A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to strengthen your portfolio with some ASX 200 blue chip shares, you may want to look at the two listed below.

Both have recently been named as buys by leading brokers. Here's why they could be the blue chip shares to buy right now:

Goodman Group (ASX: GMG)

The first ASX 200 blue chip share to look at is Goodman Group. It is a leading global integrated commercial and industrial property company with a portfolio of warehouses, large scale logistics facilities, and business and office parks.

Goldman Sachs is a big fan of the company and recently initiated coverage on its shares with a buy rating and $25.40 price target. This is largely due to strong demand for industrial properties and its burgeoning development pipeline.

Goldman said: "We continue to forecast a ~19% CAGR in AUM over FY21-24e, with AUM reaching ~A$90bn by end FY24. We forecast development completions to contribute the majority (~75%) of AUM growth over 1H22-FY24e (based on development production of ~A$7bn pa)."

ResMed Inc (ASX: RMD)

Another high quality ASX 200 blue chip share for investors to consider is ResMed. It is a global leader in the development, manufacturing, distribution, and marketing of medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders.

Analysts at Citi are very positive on the company and have a buy rating and $35.50 price target on its shares. Its analysts believe ResMed is well-placed to permanently grow its market share in the sleep treatment market due to a major competitor product recall.

The broker commented: "Despite the short-term impact [of supply chain issues], we continue to expect ResMed will make a permanent 10% market share gain in devices due to the Philips' recall."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Person holding a blue chip.
Blue Chip Shares

4 ASX 200 blue-chip shares to hold but not buy: experts

These blue-chips are worth holding if you already own them, but are too expensive for new investors to buy.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Blue Chip Shares

2 strong blue chip ASX 200 shares to buy with $20,000

Let's see why analysts think these top stocks could be buys.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Blue Chip Shares

Should you buy, hold, or sell CBA, Fortescue, and Woolworths shares?

One broker has given its verdict on these blue chips.

Read more »

Happy man working on his laptop.
Blue Chip Shares

3 ASX blue chips to buy before earnings season

Analysts recently named these shares as buys. Let's see what they are recommending.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Blue Chip Shares

2 of the best ASX 200 blue chip shares to buy now

Bell Potter sees these as the creme de la creme right now.

Read more »

Person holding a blue chip.
Opinions

Buy alert! 2 ASX 200 blue-chip shares worth a look now: expert

Dylan Evans from Catapult Wealth has identified two blue-chip shares that he thinks are good buys today.

Read more »

A group of young friends celebrating and toasting with beers
Blue Chip Shares

This beaten-down ASX 200 stock could be a turnaround story

Let's see if analysts think this stock is a buy after its heavy decline.

Read more »

A young woman sits on a sofa in a stylish home with her laptop computer balanced on her knee and smiles with a satisfied look on her face at what she's seeing on the screen.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These stocks could provide strong passive income.

Read more »